Effects of p-synephrine alone and in combination with selected bioflavo-noids on resting metabolism, blood pressure, heart rate and self-reported mood changes

International Journal of Medical Sciences

Volumn 8, Issue 4, 2011, Pages 295-301

  Stohs, Sidney J ^a   Preuss, Harry G ^b   Keith, Samuel C ^c   Keith, Patti L ^c   Miller, Howard ^d   Kaats, Gilbert R ^c  

^a CREIGHTON UNIVERSITY   (United States)

^b GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^c Integrative Health Technologies Inc   (United States)

^d Nutratech Inc   (United States)

Author keywords

Blood pressure; Heart rate; Hesperidin; Naringin; p synephrine; Resting metabolic rate

Indexed keywords

ADVANTRA Z; AURANTIIN; HESPERIDIN; OXEDRINE; PARA SYNEPHRINE; PLACEBO; UNCLASSIFIED DRUG;

ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG POTENTIATION; HEART RATE; HUMAN; HUMAN EXPERIMENT; METABOLIC RATE; MOOD; NORMAL HUMAN; PILOT STUDY; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SELF REPORT;

EID: 79958797347     PISSN: 14491907     EISSN: None     Source Type: Journal    
DOI: 10.7150/ijms.8.295     Document Type: Article

References (39)

1. Nogata Y, Sakamoto K, Shiratsuchi H, et al. Flavonoid compo-sition of fruit tissues of Citrus species. Biosci Biotech-nol.Biochem. 2006; 70: 178-192.
2. Nielson IL, Chee WSS, Poulson L, et al. Bioavailability is im-proved by enzymatic modification of the citrus flavonoid hes-peridin in humans: A randomized, double blind, crossover tri-al. J Nutr. 2006; 136: 404-408.
3. Bredsdorff L, Nielson IL, Rasmussen SE, et al. Absorption, conjugation and excretion of the flavonones, naringenin and hesperetin from alpha-rhamnosidase-treated orange juice in human subjects. Brit J Nutr. 2010; 103: 1602-1609.
4. Erlund I, Meririnne E, Alfthan G, et al. Plasma kinetics and urinary excretion of the flavonones naringenin and hesperetin in humans after ingestion of orange juice and grapefruit juice. J Nutr. 2001; 131: 235-241.
5. Erlund I, Silaste ML, Alfthan G, et al. Plasma concentrations of the flavonoids hesperetin, naringenin and quercetin in human subjects following habitual diet, and diets high or low in fruit and vegetables. Eur J Clin Nutr. 2001; 56: 891-898.
6. Manach C, Morand C, Gil-Izquierdo A, et al. Bioavailability in humans of the flavanones hesperidin and naringin after the ingestion of two doses of orange juice. Eur J Clin Nutr. 2003; 57: 235-2423.
7. Kanaze FI, Bounartzi MI, Georgarakis M, et al. Pharmakoki-netics of the citrus flavanone aglycones hesperetin and naringenin after single oral administration in human subjects. Eur J Clin Nutr. 2007; 61: 472-477.
8. Krogholm KS, Bredsdorff L, Knuthsen P, et al. Relative bioa-vailability of the flavonoids quercetin, hesperetin and naringenin given simultaneously through diet. Eur J Clin Nutr. 2010; 64: 432-435.
9. Mulvihill EE, Allister EM, Sutherland BG, et al. Naringenin prevents dyslipidemia, apolipoprotein B overproduction, and hyperinsulinemia in LDL receptor-null mice with diet induced insulin resistance. Diabetes 2009; 58: 2198-2210.
10. Kim HK, Jeong TS, Lee MK, et al. Lipid lowering efficacy of hesperetin metabolites in high-cholesterol fed rats. Clin Chim Acta 2003; 327: 129-137.
11. Bok SH, Lee SH, Park YB, et al. Plasma and hepatic cholesterol and hepatic activities of 3-hydroxy-3-methyl-glutaryl- CoA reductase and acyl CoA: cholesterol transferase are lower in rats fed citrus peel extract or a mixture of citrus bioflavonoids. J Nutr. 1999; 129: 1182-1185.
12. Ghanim H, Mohanty P, Chaudhuri A, et al. Orange juice or fructose intake does not induce oxidative and inflammatory response. Diabetes Care 2007; 30: 1406-1411.
13. Ghanim H, Sai CL, Upadhyay M, et al. Orange juice neutralizes the proinflammatory effect of a high-fat, high-carbohydrate meal and prevents endotoxin increase and Toll-like receptor expression. Amer J Clin Nutr. 2010; 91: 940-949.
14. Pari L and Shagirtha K. Hesperetin protects against oxidative stress related hepatic dysfunction by cadmium in rats. Exptl Toxicol Pathol 2010; in press.
15. Kumar A, Dogra S, Prakash A. Protective effect of naringin, a citrus flavonoid, against colchicine-induced cognitive dysfunc-tion and oxidative damage in rats. J Med Food 2010; 13: 976-984.
16. 3-Adrenoceptor agonists: potential, pitfalls and pro-gress. Eur J Pharmacol. 2002; 440: 99-107.
17. Gougeon R, Harrigan K, Tremblay JF. Increase in the thermic effect of food in women by adrenergic amines extracted from Citrus aurantium. Obesity Res. 2005; 13: 1187-1194.
18. Sale, C., Harris RC, Delves S, et al. Metabolic and physiological effects of ingesting extracts of bitter orange, green tea and guarana at rest and during treadmill walking in overweight males. Int J Obesity, 2006; 30: 764-773.
19. Stohs SJ, Shara M. A review of the safety and efficacy of Citrus aurantium in weight management. In: Bagchi D and Preuss H, eds. Obesity: Epidemiology, Pathophysiology and Prevention. Boca Raton, FL: CRC Press. 2007: 371-382.
20. Haaz S, Fontaine KR, Cutter G, Limdi N, et al. Citrus aurantium and synephrine alkaloids in the treatment of overweight and obesity: an update. Obesity Rev. 2006; 7: 79-88.
21. Haller CA, Benowitz NL, Peyton J III. Hemodynamic effects of ephedra-free weight-loss supplements in humans. Amer J Med. 2005; 118: 998-1003.
22. Pellati F, Benvenuti S, Melegari M. High-pressure liquid chro-matography methods for the analysis of adrenergic amines and flavanones in Citrus aurantium L. var. amara. Phytochem Anal. 2002;15:220-225.
23. Pellati F, Benvenuti S, Melegari M, et al. Determination of ad-renergic agonists from extracts and herbal products of Citrus aurantium L. var. amara by LC. J Pharmaceut Biomed Anal. 2004; 29: 1113-1119.
24. Roman MC, Betz JM, Hildreth J. Determination of synephrine in bitter orange raw materials, extracts, and dietary supple-ments by liquid chromatography with ultraviolet detection: single laboratory validation. J Amer Org Anal Chemists Int. 2007; 90: 68-81.
25. Mercolini L, Mandrioli R, Trere T, et al. Fast CE analysis of adrenergic amines in different parts of Citrus aurantium fruit and dietary supplements. J Sep Sci. 2010; 32: 1-8.
26. Dragull K, Breksa AP, Cain B. Synephrine content of juice from Satsuma mandarins (Citrus unshiu Marcovitch). J Agric.Food Chem. 2008; 56: 8874-8878.
27. Stohs SJ, Preuss HG. The safety of bitter orange (Citrus au-rantium) and p-synephrine. HerbalGram 2011; 89: 34-39.
28. Inchiosa MA Jr. Evidence (mostly negative) with the use of sympathomimetic agents for weight loss. J Obesity 2011; Epub.
29. Kaats GR, Preuss HG, Leckie RB. Comparative effectiveness research (CER): opportunities and challenges for the nutrition industry. J Amer Coll Nutr. 2009; 28: 234-237.
30. Calabrese EJ. Hormesis is central to toxicology, pharmacology and risk assessment. Hum Exptl Toxicol.2010; 29: 249-261.
31. Calabrese V, Cornelius C, Trovato A, et al. The hormetic role of dietary antioxidants in free radical-related diseases. Curr Pharm Des. 2010; 16: 877-883.
32. Liu L, Shan S, Zhang K, et al. Naringenin and hesperetin, two flavonoids derived from Citrus aurantium up-regulate tran-scription of adiponectin. Phytother Res. 2008; 22: 1400-1403.
33. Bent S, Padula A, Neuhaus J. Safety and efficacy of Citrus au-rantium for weight loss. Amer J Cardiol 2004; 94: 1359-1361.
34. Fugh-Berman A, Myers A. Citrus aurantium, an ingredient of dietary supplements marketed for weight loss: current status of clinical and basic research. Exptl Biol Med. 2004; 229: 698-704.
35. Haller CA, Duan M, Jacob III P, et al. Human pharmacology of a performance-enhancing dietary supplement under resting and exercise conditions. Brit J Clin Pharmacol. 2008; 65:833-840.
36. Stohs SJ. Assessment of the adverse event reports associated with Citrus aurantium (bitter orange) from April 2004 to October 2009. J Funct Foods, 2010; 2: 235-239.
37. McGuffin M. Media spins numbers on bitter orange AERs based on erroneous information from FDA. HerbalGram, 2006; 69: 52-54.
38. Riksen NP, Smits P, Rongen GA. The cardiovascular effects of methylxanthines. Handb Exptl Pharmacol. 2011; 200: 413-437.
39. Yang A, Palmer AA, De Wit H. Genetics of caffeine consump-tion and responses to coffee. Psychopharmacol. 2010; 211: 245-257.